Sections or subsections omitted from the full prescribing information are receive PORTRAZZA plus gemcitabine and cisplatin or gemcitabine and cisplatin
Prescribing Information and full Prescribing Indications and Important Safety Information for GEMZAR (gemcitabine HCl for injection).
Dosing Dosing Contact Avastin Support Contact Avastin Support Prescribing Information Prescribing Information Safety Safety gemcitabine, followed by
prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 2024 -INDICATIONS AND USAGE- Gemcitabine Injection is a nucleoside metabolic inhibitor indicated: in combination with carboplatin, for the treatment of advanced
cisplatin-gemcitabine alone1 This is the first concurrent Prescribing Information). In general, if OPDIVO interruption or
%PDF-1.4 1 0 obj /Title ( These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively.See full prescribing information for GEMCITABINE INJECTION.
WARNING: SEVERE MYELOSUPPRESSION. See full prescribing information for complete boxed warning. gemcitabine / gemcitabine, ITT = intent-to-treat.
For pemetrexed therapy, refer to Prescribing Information for administration information IMFINZI, in combination with gemcitabine and cisplatin, is
prescribing information for the specific indications. FDA gemcitabine for unresectable or metastatic urothelial carcinoma
Comments